Oral drug delivery is generally the most desirable means of administration, mainly because of patient acceptance, convenience in administration. Intestinal absorption mechanisms of anionic drugs have been mainly explained by the passive diŠusion of nonionized compounds. However, several studies have suggested the involvement of speciˆc transporters in intestinal absorption of weak acids including monocarboxylates. (-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine (nateglinide) is a oral hypoglycemic agent possessing a carboxyl group and a peptide-type bond in its structure. Although nateglinide quickly reaches the maximal serum concentration after oral administration, nateglinide itself is not transported by PepT1 or MCT1. We demonstrated that nateglinide transport occurs via a single system that is H ＋ dependent but is distinct from PepT1 or MCT1. In clinical, patients usually take many kinds of drugs at the same time. Thus, drug-drug interactions involving transporters can often directly aŠect the therapeutic safety and e‹cacy of many drugs. However, there have been few studies on food-drug interactions involving transporters. Dietary polyphenols have been widely assumed to be beneˆcial to human health. Polyphenols are commercially prepared and used as functional foods. We reported that ferulic acid, which is widely used as a functional food, aŠects the transport of clinical agents. The major dose-limiting toxicity after administration of irinotecan hydrochloride, 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxycamptothecin (CPT-11) is severe diarrhea. We have found that a speciˆc transport system mediates the uptake of active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) across the apical membrane in Caco-2 cells. Baicalin and sulfobromophthatlein inhibit this transporter. Inhibition of this transporter would be a useful means for reducing late-onset diarrhea.
Uptake of 100 mM ceftibuten into brush-border membrane vesicles was measured for 30 s with or without (control) inhibitors. Membrane vesicles were suspended in 100 mM D-mannitol, 100 mM KCl, and 20 mM MES/Tris (pH 5.5) or 20 mM HEPES/Tris (pH 7.5). The substrate mixture contained 100 mM D-mannitol, 120 mM ceftibuten, 100 mM KCl, and 20 mM MES/ Tris (pH 5.5) in the presence of various compounds. Uptake values in the absence of an inwardly directed H ＋ gradient were subtracted from those in the presence of an inwardly H ＋ gradient. Each column represents the mean with S.D. of three preparations. The control value for the uptake of ceftibuten was 610±9.88 pmol/mg of protein/30 s.   p＜0.01, signiˆcantly diŠerent from that in the absence of Gly-Sar; † † p＜0.01, signiˆcantly diŠerent from that in the absence of nateglinide. Proteoliposomes reconstituted from the 500 mM NaCl-eluted fraction of PABA-a‹nity chromatography were preincubated for 60 min with or without (control) salicylic acid. The transport experiment was started by 3-fold dilution in incubation buŠer with nateglinide and allowed to proceed for 3 min. Each column represents the mean with S.D. of three determinations.  p＜0.05,   p＜0.01, signiˆcantly diŠerent from the control. The uptake of nateglinide (50 mM) by Caco-2 cells was determined in the presence or absence of inhibitors. Each value represents the mean with S.D. of 3 6 preparations. The control value for the uptake of nateglinide was 12.3±2.12 nmol/mg protein/5 min.  p＜0.01, signiˆcantly diŠerent from the control. 
